Aptorum Total Liab from 2010 to 2025

APM Stock  USD 1.60  0.01  0.62%   
Aptorum Group Total Liabilities yearly trend continues to be very stable with very little volatility. Total Liabilities is likely to grow to about 7.1 M this year. Total Liabilities is the total amount of all liabilities that Aptorum Group Ltd has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
2017-12-31
Previous Quarter
5.3 M
Current Value
5.3 M
Quarterly Volatility
4.9 M
 
Covid
Check Aptorum Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Aptorum Group's main balance sheet or income statement drivers, such as Interest Expense of 103.6 K, Selling General Administrative of 6.7 M or Total Revenue of 701.1 K, as well as many indicators such as Price To Sales Ratio of 28.05, Dividend Yield of 0.0079 or PTB Ratio of 0.49. Aptorum financial statements analysis is a perfect complement when working with Aptorum Group Valuation or Volatility modules.
  
Check out the analysis of Aptorum Group Correlation against competitors.

Latest Aptorum Group's Total Liab Growth Pattern

Below is the plot of the Total Liab of Aptorum Group Ltd over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. Aptorum Group's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Aptorum Group's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

Aptorum Total Liab Regression Statistics

Arithmetic Mean4,161,866
Geometric Mean1,559,806
Coefficient Of Variation107.66
Mean Deviation3,759,418
Median4,401,121
Standard Deviation4,480,476
Sample Variance20.1T
Range12.8M
R-Value0.69
Mean Square Error11.2T
R-Squared0.48
Significance0
Slope651,575
Total Sum of Squares301.1T

Aptorum Total Liab History

20257.1 M
2024M
20235.3 M
202213 M
20214.4 M
20206.1 M
20199.1 M

About Aptorum Group Financial Statements

Aptorum Group investors utilize fundamental indicators, such as Total Liab, to predict how Aptorum Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total LiabilitiesM7.1 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Aptorum Group is a strong investment it is important to analyze Aptorum Group's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Aptorum Group's future performance. For an informed investment choice regarding Aptorum Stock, refer to the following important reports:
Check out the analysis of Aptorum Group Correlation against competitors.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aptorum Group. If investors know Aptorum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aptorum Group listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
0.23
Revenue Per Share
0.095
Quarterly Revenue Growth
(1.00)
Return On Assets
(0.32)
Return On Equity
(0.37)
The market value of Aptorum Group is measured differently than its book value, which is the value of Aptorum that is recorded on the company's balance sheet. Investors also form their own opinion of Aptorum Group's value that differs from its market value or its book value, called intrinsic value, which is Aptorum Group's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aptorum Group's market value can be influenced by many factors that don't directly affect Aptorum Group's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Aptorum Group's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aptorum Group is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aptorum Group's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.